Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.45
+0.07 (1.30%)
At close: Jul 20, 2026, 4:00 PM EDT
5.46
+0.01 (0.20%)
Pre-market: Jul 21, 2026, 5:00 AM EDT
Unicycive Therapeutics Employees
As of December 31, 2025, Unicycive Therapeutics had 22 total employees, including 21 full-time and 1 part-time employees. The number of employees decreased by 1 or -4.35% compared to the previous year.
Employees
22
Change (1Y)
-1
Growth (1Y)
-4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,813,091
Market Cap
149.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | -1 | -4.35% | 21 | 1 |
| Dec 31, 2024 | 23 | 9 | 64.29% | 22 | 1 |
| Dec 31, 2023 | 14 | 2 | 16.67% | 14 | 0 |
| Dec 31, 2022 | 12 | 3 | 33.33% | 12 | 0 |
| Dec 31, 2021 | 9 | 8 | 800.00% | 9 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Molecular Partners AG | 134 |
| Cibus | 118 |
| Connect Biopharma Holdings | 64 |
| PepGen | 59 |
| Pyxis Oncology | 56 |
| Milestone Pharmaceuticals | 38 |
| TuHURA Biosciences | 22 |
UNCY News
- 19 days ago - Unicycive Therapeutics price target lowered to $50 from $60 at Noble Capital - TheFly
- 19 days ago - Unicycive Therapeutics price target lowered to $13 from $18 at Benchmark - TheFly
- 20 days ago - Johnson Fistel Investigates Unicycive Therapeutics, Inc. (NASDAQ: UNCY) on Behalf of Investors - GlobeNewsWire
- 20 days ago - Unicycive Therapeutics price target lowered to $15 from $22 at H.C. Wainwright - TheFly
- 20 days ago - Unicycive Therapeutics CRL tied to same vendor deficiency, says B. Riley - TheFly
- 20 days ago - Unicycive Therapeutics receives complete response letter from FDA for OLC NDA - TheFly
- 20 days ago - Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA) - GlobeNewsWire
- 4 weeks ago - Unicycive Therapeutics Proxy statement: Proxy filing - Filings